Motivated by our previous evidence that TRIM9 promoted CEACAM6-Smad2/3 signaling to facilitate bladder cancer cell proliferation/migration, we next sought to evaluated the influence of TRIM9 on tumor growth in vivo. This evidence concerns the gene SMAD2 and urinary bladder carcinoma.